This is a Validated Antibody Database (VAD) review about mouse E2f1, based on 56 published articles (read how Labome selects the articles), using E2f1 antibody in all methods. It is aimed to help Labome visitors find the most suited E2f1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
E2f1 synonym: E2F-1; Tg(Wnt1-cre)2Sor; mKIAA4009

Knockout validation
Invitrogen
mouse monoclonal (KH95)
  • western blot; human; loading ...; fig 5b
  • western blot knockout validation; mouse; loading ...; fig 3d
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Invitrogen E2f1 antibody (ThermoFisher, 32-1400) was used in western blot on human samples (fig 5b) and in western blot knockout validation on mouse samples (fig 3d). Mol Pharmacol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (KH95)
  • western blot; human; 1:500; loading ...; fig 5j
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on human samples at 1:500 (fig 5j). Cancer Res (2021) ncbi
mouse monoclonal (KH95)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in western blot on human samples (fig 5a). Oncogene (2021) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:500; loading ...; fig 4g
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on human samples at 1:500 (fig 4g). Mol Metab (2021) ncbi
mouse monoclonal (KH95)
  • flow cytometry; human; 1:100; loading ...; fig s5e
Santa Cruz Biotechnology E2f1 antibody (Santa, sc-251) was used in flow cytometry on human samples at 1:100 (fig s5e). Science (2020) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; loading ...; fig 2d
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; loading ...; fig 1b
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH-95) was used in chromatin immunoprecipitation on human samples (fig 2d), in immunoprecipitation on human samples (fig 1a), in immunocytochemistry on human samples (fig 1b) and in western blot on human samples (fig 2a). Theranostics (2019) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:500; loading ...; fig 6f
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in western blot on human samples at 1:500 (fig 6f). Cancers (Basel) (2019) ncbi
mouse monoclonal (KH95)
  • western blot; human; loading ...; fig 4e
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in western blot on human samples (fig 4e). Cancer Lett (2019) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology E2f1 antibody (Santa, KH95) was used in chromatin immunoprecipitation on human samples (fig 2c) and in western blot on human samples (fig 2b). Sci Rep (2018) ncbi
mouse monoclonal (KH95)
  • other; human; loading ...; fig 4c
Santa Cruz Biotechnology E2f1 antibody (SantaCruz, sc-251) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (KH95)
  • western blot; mouse; 1:750; fig s14d
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, Sc-251) was used in western blot on mouse samples at 1:750 (fig s14d). Development (2017) ncbi
mouse monoclonal (KH95)
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in western blot on mouse samples (fig 1b). Mol Cell Biol (2017) ncbi
mouse monoclonal (KH129)
  • western blot; human; fig 4
Santa Cruz Biotechnology E2f1 antibody (Santa cruz, sc-56661) was used in western blot on human samples (fig 4). Mol Cells (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; loading ...; fig 6b
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in western blot on human samples (fig 6b). PLoS ONE (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:200; fig 5c
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in western blot on human samples at 1:200 (fig 5c). Cancer Chemother Pharmacol (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; fig 1
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in western blot on human samples (fig 1). elife (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:500; loading ...; fig 2a
In order to describe how a CHK1 inhibitor reduces the growth of radioresistant breast cancer cells, Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on human samples at 1:500 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (KH95)
  • western blot; mouse; 1:500; fig 6
In order to elucidate induction of p53-dependent and independent apoptosis to compromise cellular proliferation and inhibition of tumor formation by dysfunctional telomeres, Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on mouse samples at 1:500 (fig 6). Aging Cell (2016) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in chromatin immunoprecipitation on human samples (fig 4a) and in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:500; fig s2
Santa Cruz Biotechnology E2f1 antibody (santa Cruz, sc-251) was used in western blot on human samples at 1:500 (fig s2). Oncotarget (2016) ncbi
mouse monoclonal (KH95)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology E2f1 antibody (SCBT, KH95) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (KH95)
  • western blot; human; fig 2
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry; mouse; 1:25; fig 2
  • immunohistochemistry; human; 1:25; fig 7
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in immunohistochemistry on mouse samples at 1:25 (fig 2) and in immunohistochemistry on human samples at 1:25 (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (KH95)
  • western blot; human; fig 5
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in western blot on human samples (fig 5). J Biol Chem (2015) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; fig S2
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in chromatin immunoprecipitation on human samples (fig S2). Oncotarget (2015) ncbi
mouse monoclonal (KH129)
  • western blot; human; loading ...; fig 6e
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-56661) was used in western blot on human samples (fig 6e). BMC Cancer (2015) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:500; fig 6
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in western blot on human samples at 1:500 (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (KH95)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, KH95) was used in western blot on mouse samples (fig 1). Acta Pharmacol Sin (2015) ncbi
mouse monoclonal (KH95)
  • western blot; human; 1:200; loading ...; fig 3a
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in western blot on human samples at 1:200 (fig 3a). Oncogene (2016) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; fig 5b
  • immunoprecipitation; human; fig 7d
  • western blot; human; fig 6b
Santa Cruz Biotechnology E2f1 antibody (Santa, SC-251) was used in chromatin immunoprecipitation on human samples (fig 5b), in immunoprecipitation on human samples (fig 7d) and in western blot on human samples (fig 6b). Oncotarget (2014) ncbi
mouse monoclonal (KH95)
  • western blot; human
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, KH95) was used in western blot on human samples . Breast Cancer Res (2014) ncbi
mouse monoclonal (KH95)
  • western blot; human
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, SC251) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, KH95) was used in chromatin immunoprecipitation on human samples , in immunoprecipitation on human samples and in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in chromatin immunoprecipitation on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; human; fig 2
  • EMSA; human; fig 2
  • western blot; human; fig s3
In order to study the role of the RIP140 gene as a new transcriptional target of E2F1, Santa Cruz Biotechnology E2f1 antibody (Santa Cruz, sc-251) was used in chromatin immunoprecipitation on human samples (fig 2), in EMSA on human samples (fig 2) and in western blot on human samples (fig s3). PLoS ONE (2012) ncbi
mouse monoclonal (KH95)
  • western blot; human
Santa Cruz Biotechnology E2f1 antibody (Santa Cruz Biotechnology, sc-251) was used in western blot on human samples . Oncogene (2008) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 5j
Abcam E2f1 antibody (Abcam, ab5391) was used in western blot on human samples at 1:500 (fig 5j). Cancer Res (2021) ncbi
mouse monoclonal (KH95)
  • ChIP-Seq; human; loading ...; fig 5a
Abcam E2f1 antibody (Abcam, ab4070) was used in ChIP-Seq on human samples (fig 5a). Nat Commun (2020) ncbi
mouse monoclonal (KH95)
  • western blot; human; fig 2b
Abcam E2f1 antibody (Abcam, KH95) was used in western blot on human samples (fig 2b). Biosci Rep (2018) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; fig 4b
Abcam E2f1 antibody (Abcam, 137415) was used in immunoprecipitation on mouse samples (fig 4b). elife (2016) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 6
Abcam E2f1 antibody (Abcam, ab4070) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6). Nat Commun (2015) ncbi
Invitrogen
mouse monoclonal (KH95)
  • western blot; human; loading ...; fig 5b
  • western blot knockout validation; mouse; loading ...; fig 3d
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Invitrogen E2f1 antibody (ThermoFisher, 32-1400) was used in western blot on human samples (fig 5b) and in western blot knockout validation on mouse samples (fig 3d). Mol Pharmacol (2017) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study the clinical manifestation of Alzheimer's disease involving cell-cycle regulation, neuronal death and repair of oxidative DNA damage, Invitrogen E2f1 antibody (NeoMarkers, KH95) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry - paraffin section; human; 1:200
In order to identify the prognostic markers of resectable hepatocellular carcinomas, Invitrogen E2f1 antibody (Invitrogen, 32-1400) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hepatology (2014) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry - paraffin section; human; 1:20
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen E2f1 antibody (Lab Vision, MS-879) was used in immunohistochemistry - paraffin section on human samples at 1:20. Int J Oncol (2012) ncbi
mouse monoclonal (KH95)
  • chromatin immunoprecipitation; mouse; fig 7
  • western blot; mouse; fig 6
In order to elucidate the molecular mechanism of HDAC-mediated regulation of Apaf-1, Invitrogen E2f1 antibody (Zymed, 32-1400) was used in chromatin immunoprecipitation on mouse samples (fig 7) and in western blot on mouse samples (fig 6). J Neurosci Res (2009) ncbi
mouse monoclonal (KH95)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to assess expression and prognostic significance of E2F-1 and thymidylate synthase in R(0)-resected gastric adenocarcinoma patients, Invitrogen E2f1 antibody (Zymed, KH95) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Clin Cancer Res (2008) ncbi
mouse monoclonal (KH95)
  • western blot; mouse
In order to determine whether N-Myc overexpression is highly oncogenic in mouse myeloid cells, Invitrogen E2f1 antibody (Zymed, KH95) was used in western blot on mouse samples . Cancer Res (2007) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology E2f1 antibody (Cell Signal, 3742) was used in western blot on human samples (fig 2d). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig s3e
Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in immunohistochemistry on human samples (fig s3e). EBioMedicine (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in western blot on human samples (fig 1a). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology E2f1 antibody (Cell Signalling, 3742S) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • chromatin immunoprecipitation; human; 1:100; loading ...; fig 6g
Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in chromatin immunoprecipitation on human samples at 1:100 (fig 6g). Oncol Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:3000; loading ...; fig 7a
Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in western blot on human samples at 1:3000 (fig 7a). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Cell Signaling Technology E2f1 antibody (CST, 3742) was used in western blot on human samples (fig s3a). Science (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in western blot on human samples (fig 1). Neuroendocrinology (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 4c
In order to study the effects of fangchinoline treatment on SPC-A-1 lung cancer cells, Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in western blot on human samples at 1:2000 (fig 4c). Exp Ther Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3
In order to investigate factors that control PHD1 activity, Cell Signaling Technology E2f1 antibody (Cell Signaling, 3742) was used in western blot on human samples at 1:1000 (fig 3). J Cell Sci (2016) ncbi
Articles Reviewed
  1. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  2. Laine A, Nagelli S, Farrington C, Butt U, Cvrljevic A, Vainonen J, et al. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer Res. 2021;81:4319-4331 pubmed publisher
  3. Fischietti M, Eckerdt F, Blyth G, Arslan A, Mati W, Oku C, et al. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 2021;40:3273-3286 pubmed publisher
  4. Malvi P, Janostiak R, Nagarajan A, Zhang X, Wajapeyee N. N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production. Mol Metab. 2021;48:101217 pubmed publisher
  5. Zatulovskiy E, Zhang S, Berenson D, Topacio B, Skotheim J. Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division. Science. 2020;369:466-471 pubmed publisher
  6. Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nat Commun. 2020;11:594 pubmed publisher
  7. Xu Q, Ge Q, Zhou Y, Yang B, Yang Q, Jiang S, et al. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. EBioMedicine. 2020;51:102609 pubmed publisher
  8. Patel H, Tao N, Lee K, Huerta M, Arlt H, Mullarkey T, et al. Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors. Breast Cancer Res. 2019;21:146 pubmed publisher
  9. Liu P, Tee A, Milazzo G, Hannan K, Maag J, Mondal S, et al. The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. Nat Commun. 2019;10:5026 pubmed publisher
  10. Zhang L, Tian S, Pei M, Zhao M, Wang L, Jiang Y, et al. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer. Oncol Rep. 2019;42:2655-2669 pubmed publisher
  11. Goody D, Gupta S, Engelmann D, Spitschak A, Marquardt S, Mikkat S, et al. Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers. Theranostics. 2019;9:1490-1509 pubmed publisher
  12. Barger C, Branick C, Chee L, Karpf A. Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer. Cancers (Basel). 2019;11: pubmed publisher
  13. Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
  14. Yang Y, Peng X. The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through the ATM-E2F1 signaling pathway. Biosci Rep. 2018;38: pubmed publisher
  15. Komori H, Goto Y, Kurayoshi K, Ozono E, Iwanaga R, Bradford A, et al. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes. Sci Rep. 2018;8:8438 pubmed publisher
  16. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  17. Fang J, Coon B, Gillis N, Chen Z, Qiu J, Chittenden T, et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun. 2017;8:2149 pubmed publisher
  18. Martín Ibáñez R, Pardo M, Giralt A, Miguez A, Guardia I, Marion Poll L, et al. Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons. Development. 2017;144:1566-1577 pubmed publisher
  19. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  20. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  21. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  22. Swartz K, Wood S, Murthy T, Ramirez O, Qin G, Pillai M, et al. E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts. Mol Cell Biol. 2017;37: pubmed publisher
  23. You D, Zhao H, Wang Y, Jiao Y, Lu M, Yan S. Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation. Mol Cells. 2016;39:663-8 pubmed publisher
  24. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  25. Fiedor E, Gregoraszczuk E. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines. Cancer Chemother Pharmacol. 2016;78:611-22 pubmed publisher
  26. Hossain M, Stillman B. Opposing roles for DNA replication initiator proteins ORC1 and CDC6 in control of Cyclin E gene transcription. elife. 2016;5: pubmed publisher
  27. Zhang Y, Lai J, Du Z, Gao J, Yang S, Gorityala S, et al. Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget. 2016;7:34688-702 pubmed publisher
  28. Wang Y, Wang X, Flores E, Yu J, Chang S. Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation. Aging Cell. 2016;15:646-60 pubmed publisher
  29. Emechebe U, Kumar P P, Rozenberg J, Moore B, Firment A, Mirshahi T, et al. T-box3 is a ciliary protein and regulates stability of the Gli3 transcription factor to control digit number. elife. 2016;5: pubmed publisher
  30. Wang C, Chen Y, Wang C, Yu J, Chang Y, Yu C. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells. Oncotarget. 2016;7:25432-42 pubmed publisher
  31. Tambe M, Pruikkonen S, Mäki Jouppila J, Chen P, Elgaaen B, Straume A, et al. Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel. Oncotarget. 2016;7:12267-85 pubmed publisher
  32. Luo X, Peng J, Su L, Wang D, Yu Y. Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression. Exp Ther Med. 2016;11:613-618 pubmed
  33. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  34. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  35. Tarangelo A, Lo N, Teng R, Kim E, Le L, Watson D, et al. Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression. Nat Commun. 2015;6:10028 pubmed publisher
  36. Cataldo A, Cheung D, Balsari A, Tagliabue E, Coppola V, Iorio M, et al. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 2016;7:786-97 pubmed publisher
  37. Wang B, Ma A, Zhang L, Jin W, Qian Y, Xu G, et al. POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. Nat Commun. 2015;6:8704 pubmed publisher
  38. Mahanic C, Budhavarapu V, Graves J, Li G, Lin W. Regulation of E2 promoter binding factor 1 (E2F1) transcriptional activity through a deubiquitinating enzyme, UCH37. J Biol Chem. 2015;290:26508-22 pubmed publisher
  39. Bida O, Gidoni M, Ideses D, Efroni S, Ginsberg D. A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget. 2015;6:27880-90 pubmed publisher
  40. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed publisher
  41. Barger C, Zhang W, Hillman J, Stablewski A, Higgins M, Vanderhyden B, et al. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Oncotarget. 2015;6:27613-27 pubmed publisher
  42. Ma Q, Hu Q, Xu R, Zhen X, Wang G. Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1. Acta Pharmacol Sin. 2015;36:966-75 pubmed publisher
  43. Wang Y, Deng O, Feng Z, Du Z, Xiong X, Lai J, et al. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene. 2016;35:1363-72 pubmed publisher
  44. Chen D, Ming L, Zou F, Peng Y, Van Houten B, Yu J, et al. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Oncotarget. 2014;5:8107-22 pubmed
  45. Silva A, Santos A, Farfel J, Grinberg L, Ferretti R, Campos A, et al. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease. PLoS ONE. 2014;9:e99897 pubmed publisher
  46. Aguilar H, Urruticoechea A, Halonen P, Kiyotani K, Mushiroda T, Barril X, et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014;16:R53 pubmed publisher
  47. Ahn S, Jang S, Shim J, Kim D, Hong S, Sung C, et al. Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology. 2014;60:1972-82 pubmed publisher
  48. Wojdyla L, Stone A, Sethakorn N, Uppada S, Devito J, Bissonnette M, et al. T-oligo as an anticancer agent in colorectal cancer. Biochem Biophys Res Commun. 2014;446:596-601 pubmed publisher
  49. Zhang W, Ji W, Liu X, Ouyang G, Xiao W. ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1. Mol Cell Biol. 2014;34:765-75 pubmed publisher
  50. Ogiwara H, Kohno T. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes. PLoS ONE. 2012;7:e52810 pubmed publisher
  51. Docquier A, Augereau P, Lapierre M, Harmand P, Badia E, Annicotte J, et al. The RIP140 gene is a transcriptional target of E2F1. PLoS ONE. 2012;7:e35839 pubmed publisher
  52. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  53. Wallace D, Cotter T. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina. J Neurosci Res. 2009;87:887-905 pubmed publisher
  54. Britschgi A, Trinh E, Rizzi M, Jenal M, Ress A, Tobler A, et al. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function. Oncogene. 2008;27:5706-16 pubmed publisher
  55. Lee J, Park C, Park J, Lim T, Park Y, Lim H, et al. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res. 2008;14:82-8 pubmed publisher
  56. Kawagoe H, Kandilci A, Kranenburg T, Grosveld G. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice. Cancer Res. 2007;67:10677-85 pubmed